Back to All Events

Drug Development Regulatory Pathways Across the Globe

Drug Development Regulatory Pathways Across the Globe

Join this event to explore examples of how biotech companies navigated regulatory hurdles.

​Presentations and a panel discussion will assess key differences in global regulatory processes, especially between the U.S. and Canada, and will dive deeper into start-up regulatory strategy and how companies can acquire government approval for their products across different jurisdictions.

Clarissa Jepson (Program Analyst, Capital Access) and Gaayatiri Pushparaj (Program Analyst, Technology Adoption) from OBIO® will be attending this event.

Previous
Previous
November 18

The Forge Startup Survivor Pitch Competition

Next
Next
November 23

Healthcare Collaboration Exchange 2026